Product NDC: | 68180-137 |
Proprietary Name: | Escitalopram |
Non Proprietary Name: | Escitslopram |
Active Ingredient(s): | 5 mg/1 & nbsp; Escitslopram |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68180-137 |
Labeler Name: | Lupin Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078169 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120910 |
Package NDC: | 68180-137-06 |
Package Description: | 30 TABLET in 1 BOTTLE (68180-137-06) |
NDC Code | 68180-137-06 |
Proprietary Name | Escitalopram |
Package Description | 30 TABLET in 1 BOTTLE (68180-137-06) |
Product NDC | 68180-137 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Escitslopram |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120910 |
Marketing Category Name | ANDA |
Labeler Name | Lupin Pharmaceuticals, Inc. |
Substance Name | ESCITALOPRAM OXALATE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |